We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$9.13B
AUM Growth
+$334M
Cap. Flow
-$281M
Cap. Flow %
-3.08%
Top 10 Hldgs %
21.52%
Holding
2,368
New
73
Increased
154
Reduced
1,152
Closed
75

Sector Composition

Rank Sector Weight
1 Technology 22.17%
2 Healthcare 13.84%
3 Financials 12.41%
4 Consumer Discretionary 11.36%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EIX icon
326
Edison International
EIX
$26.7B
$4.88M 0.05%
95,894
-2,951
-3% -$157K
HELE icon
327
Helen of Troy
HELE
$696M
$4.85M 0.05%
25,064
-1,041
-4% -$207K
MPC icon
328
Marathon Petroleum
MPC
$97.8B
$4.84M 0.05%
164,979
-5,088
-3% -$179K
EFX icon
329
Equifax
EFX
$21.2B
$4.83M 0.05%
30,794
-952
-3% -$156K
QDEL icon
330
QuidelOrtho
QDEL
$1.02B
$4.79M 0.05%
21,857
-840
-4% -$187K
TTWO icon
331
Take-Two Interactive
TTWO
$45.4B
$4.79M 0.05%
28,990
-810
-3% -$132K
FRC
332
DELISTED
First Republic Bank
FRC
$4.76M 0.05%
43,639
-1,206
-3% -$134K
TREX icon
333
Trex
TREX
$5.05B
$4.75M 0.05%
66,275
-2,437
-4% -$169K
AMP icon
334
Ameriprise Financial
AMP
$49.9B
$4.7M 0.05%
30,493
-1,502
-5% -$231K
ARE icon
335
Alexandria Real Estate Equities
ARE
$8.27B
$4.7M 0.05%
29,351
-3,377
-10% -$564K
KEYS icon
336
Keysight
KEYS
$60.6B
$4.69M 0.05%
47,447
-1,469
-3% -$144K
CONE
337
DELISTED
CyrusOne Inc Common Stock
CONE
$4.69M 0.05%
66,914
-1,498
-2% -$117K
LH icon
338
Labcorp
LH
$26.2B
$4.65M 0.05%
28,745
-845
-3% -$134K
MKTX icon
339
MarketAxess Holdings
MKTX
$5.72B
$4.64M 0.05%
9,628
-288
-3% -$142K
SAM icon
340
Boston Beer
SAM
$1.89B
$4.61M 0.05%
5,216
-519
-9% -$410K
EBS icon
341
Emergent Biosolutions
EBS
$233M
$4.6M 0.05%
44,470
+24,459
+122% +$2.64M
LYB icon
342
LyondellBasell Industries
LYB
$20.3B
$4.59M 0.05%
65,174
-2,028
-3% -$140K
MXIM
343
DELISTED
Maxim Integrated Products
MXIM
$4.58M 0.05%
67,690
-2,042
-3% -$138K
AKAM icon
344
Akamai
AKAM
$17.6B
$4.56M 0.05%
41,252
-1,188
-3% -$132K
VMC icon
345
Vulcan Materials
VMC
$36.3B
$4.55M 0.05%
33,581
-1,054
-3% -$132K
JAZZ icon
346
Jazz Pharmaceuticals
JAZZ
$16.2B
$4.53M 0.05%
+31,753
New +$3.94M
RGLD icon
347
Royal Gold
RGLD
$19.7B
$4.51M 0.05%
37,554
-1,392
-4% -$183K
DFS
348
DELISTED
Discover Financial Services
DFS
$4.49M 0.05%
77,691
-2,417
-3% -$127K
VLO icon
349
Valero Energy
VLO
$95.1B
$4.48M 0.05%
103,384
-3,243
-3% -$170K
CMS icon
350
CMS Energy
CMS
$22B
$4.46M 0.05%
72,584
-2,273
-3% -$139K

Similar funds

MetLife Investment Management's Q3 2020 Portfolio in Review

As of Q3 2020, MetLife Investment Management held 2,368 positions worth $9.13B, up 3.8% from $8.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management withdrew a net $281M in Q3 2020, closing 75 positions and reducing 1,152 holdings. Its most notable exit was Slack Technologies, Inc., an estimated $7.44M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Jazz Pharmaceuticals worth $4.53M.

  • MetLife Investment Management's largest Q3 2020 buy was Jazz Pharmaceuticals: 31,753 shares worth $4.53M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $34.6M increase.
  • MetLife Investment Management's biggest Q3 2020 reduction was Apple, cutting an estimated $22.2M.
  • MetLife Investment Management fully exited Slack Technologies, Inc. in Q3 2020, selling an estimated $7.44M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $9.13B portfolio in Q3 2020.
  • MetLife Investment Management opened 73 new positions and closed 75 in Q3 2020.
  • MetLife Investment Management's portfolio value rose 3.8% quarter-over-quarter to $9.13B.

Based on MetLife Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.